journal
https://read.qxmd.com/read/38563735/cyclosporine-associated-organizing-pneumonia
#1
JOURNAL ARTICLE
Harjinder Singh, Parth Patel, Samih Mawari, Neil Caliman
No abstract text is available yet for this article.
April 2, 2024: American Journal of Therapeutics
https://read.qxmd.com/read/38557480/the-nocebo-effect-a-bias-in-clinical-practice-an-ethical-approach
#2
JOURNAL ARTICLE
Iulia-Virginia Răducan-Florea, Florin G Leaşu, Eleonora A Dinu, Liliana M Rogozea
BACKGROUND: The nocebo effect is often disregarded in medical practice and is certainly much less known than the placebo effect, although, in reality, both can influence therapeutic decision making and the quality of life of patients. However, the nocebo effect raises a number of issues not only of a practical nature related to clinical activity but also ethical dilemmas related to the observance of the patient's autonomy, nonmaleficence, or informed consent and the information on which it is based...
April 2, 2024: American Journal of Therapeutics
https://read.qxmd.com/read/38547374/advances-in-the-pharmacological-management-of-chronic-hepatitis-b
#3
JOURNAL ARTICLE
Cella Danielescu, Monica State, Radu Bogdan Mateescu
BACKGROUND: Hepatitis B, a vaccine-preventable liver infection, remains a global public health problem. Dedicated groups of experts and funding are focusing on achieving a functional cure to eradicate this disease by 2030. AREAS OF UNCERTAINTY: With more than 40 molecules available or under investigation as new treatments for hepatitis B virus (HBV) infection, none of them is curative so far. Available treatments are effective in suppressing HBV replication and in decreasing the risk of developing cirrhosis, liver failure, hepatocellular carcinoma, and death, but do not eliminate the virus, and the risk of hepatocellular carcinoma remains...
March 27, 2024: American Journal of Therapeutics
https://read.qxmd.com/read/38526291/delayed-response-to-glucocorticoids-in-daptomycin-lung
#4
JOURNAL ARTICLE
Abdelrahman Nanah, Anika Sasidharan Nair, James Stoller
No abstract text is available yet for this article.
March 26, 2024: American Journal of Therapeutics
https://read.qxmd.com/read/38525959/the-effect-of-abcb1-and-ces1-polymorphisms-on-plasma-levels-of-dabigatran-and-risk-of-hemorrhagic-complications-in-ischemic-stroke-patients
#5
JOURNAL ARTICLE
Olšerová Anna, Janský Petr, Magerová Hana, Šrámková Tereza, Kešnerová Petra, Kmetonyová Silvia, Šulc Vlastimil, Halmová Hana, Šrámek Martin, Šarbochová Ivana, Paulasová-Schwabová Jaroslava, Benešová Kateřina, Macek Jan, Maťoška Václav, Tomek Aleš
BACKGROUND: Dabigatran directly inhibits thrombin and is used in primary and secondary stroke prevention in individuals with nonvalvular atrial fibrillation. The prodrug dabigatran etexilate is absorbed by enteral P-glycoprotein (ABCB1) and then activated by hepatic and intestinal carboxylesterases (CES1) to produce active metabolites. Variations in dabigatran metabolism because of genetics may affect concentration levels and clinical outcomes. STUDY QUESTION: We conducted a study to assess how polymorphisms in the CES1 (rs2244613) and ABCB1 (rs4148738) genes affect the through plasma level (cmin) of dabigatran and its correlation to clinical outcomes...
March 20, 2024: American Journal of Therapeutics
https://read.qxmd.com/read/38525955/jak-inhibitors-for-treating-steroid-dependent-iga-vasculitis
#6
JOURNAL ARTICLE
Qingmiao Sun, Juan Bai, Su Wang, Hong Fang, Jianjun Qiao
No abstract text is available yet for this article.
March 20, 2024: American Journal of Therapeutics
https://read.qxmd.com/read/38525954/dimethyl-fumarate-associated-enterocolitis
#7
JOURNAL ARTICLE
Numra A Bajwa, Azka A Bajwa, Seham Ghazala, Umair Masood
No abstract text is available yet for this article.
March 20, 2024: American Journal of Therapeutics
https://read.qxmd.com/read/38525942/efficacy-of-abrocitinib-for-the-treatment-of-moderate-to-severe-atopic-dermatitis-in-real-world-practice-in-a-single-center
#8
JOURNAL ARTICLE
Juan Bai, Wang Su, Hong Fang, Jianjun Qiao
No abstract text is available yet for this article.
March 20, 2024: American Journal of Therapeutics
https://read.qxmd.com/read/38563758/effects-of-mavacamten-concomitant-with-beta-blockers-on-patients-with-hypertrophic-cardiomyopathy-a-meta-analysis-of-randomized-controlled-trials
#9
JOURNAL ARTICLE
Syeda Tayyaba Rehan, Abraish Ali, Laiba Imran, Jawad Ahmed, Irfan Ullah, Abdelrahman Sherif Abdalla, Muhammad Majid, Muhammad Sohaib Asghar
No abstract text is available yet for this article.
March 12, 2024: American Journal of Therapeutics
https://read.qxmd.com/read/38460175/levodopa-carbidopa-entacapone-intestinal-gel-in-advanced-parkinson-disease-a-multicenter-real-life-experience
#10
JOURNAL ARTICLE
József Attila Szász, Adriana Octaviana Dulamea, Viorelia Adelina Constantin, Dafin Fior Mureşanu, Lăcrămioara Perju Dumbravă, Cristina Tiu, Dragoş Cătălin Jianu, Mihaela Simu, Amalia Ene, Any Axelerad, Cristian Falup-Pecurariu, Mihaela Lungu, Adina Gabriela Danci, Monica Sabau, Ştefan Strilciuc, Bogdan Ovidiu Popescu
BACKGROUND: For Parkinson disease (PD) patients who have been diagnosed with advanced disease that can no longer be effectively controlled with optimized oral or transdermal medications, a range of device-aided therapies (DAT) are available, comprising either deep brain stimulation or infusion therapies providing continuous dopaminergic stimulation. Levodopa-entacapone-carbidopa intestinal gel (LECIG) infusion is the latest DAT for advanced PD (APD) that was approved in Romania in 2021...
March 8, 2024: American Journal of Therapeutics
https://read.qxmd.com/read/38460172/cognitive-decline-after-s-ketamine-use
#11
JOURNAL ARTICLE
Mingguo Li, Yuanyuan Yang, Zhiqiang Zhao, Long Chen, Zhenliang Pan
No abstract text is available yet for this article.
March 8, 2024: American Journal of Therapeutics
https://read.qxmd.com/read/38417012/hepatitis-b-virus-reactivation-after-pralsetinib-targeted-therapy-in-a-patient-with-non-small-cell-lung-cancer
#12
JOURNAL ARTICLE
Yifei Xie, Cheng Chen, Jian-An Huang
No abstract text is available yet for this article.
February 28, 2024: American Journal of Therapeutics
https://read.qxmd.com/read/38335060/atezolizumab-associated-retiform-purpura
#13
JOURNAL ARTICLE
Sabeen Sidiki, Rawish Fatima, Nahimarys Colón Hernández, Nezam Altorok
No abstract text is available yet for this article.
February 9, 2024: American Journal of Therapeutics
https://read.qxmd.com/read/38305826/comparative-analysis-of-risk-prediction-scores-for-treatment-emergent-atrial-fibrillation-among-patients-with-chronic-lymphocytic-leukemia-treated-with-ibrutinib
#14
JOURNAL ARTICLE
Akhilesh Babbili, Rachaita Lakra, Sahith Reddy Thotamgari, Shiva Jashwanth Gaddam, Udhayvir Singh Grewal, Paari Dominic
No abstract text is available yet for this article.
February 2, 2024: American Journal of Therapeutics
https://read.qxmd.com/read/38300762/cilostazol-in-patients-with-high-residual-platelet-reactivity-after-drug-eluting-stent-implantation
#15
JOURNAL ARTICLE
Schiera Eleonora, Terracina Sergio, Pulcinelli Fabio Maria
No abstract text is available yet for this article.
January 31, 2024: American Journal of Therapeutics
https://read.qxmd.com/read/38260985/favipiravir-for-the-treatment-of-hospitalized-patients-with-covid-19-a-systematic-review-and-meta-analysis-of-randomized-controlled-trials
#16
JOURNAL ARTICLE
Aiman Naveed, Huzaifa Ahmad Cheema, Abia Shahid, Mohammad Umer, Hassan Ul Hussain, Mohammad Ebad Ur Rehman, Harpreet Singh, Jonathan S Kurman, Syeda Sahra, Faran Ahmad, Sharjeel Ahmad, Sana Iqbal
No abstract text is available yet for this article.
January 23, 2024: American Journal of Therapeutics
https://read.qxmd.com/read/38260974/resumption-of-regular-drugs-in-emergency-patients-admitted-to-the-intensive-care-unit
#17
JOURNAL ARTICLE
Akio Adachi, Takeo Yasu, Hideaki Enomoto, Misato Sekine, Takayuki Omori, Yasumasa Tsuda, Kazumi Goto
No abstract text is available yet for this article.
January 23, 2024: American Journal of Therapeutics
https://read.qxmd.com/read/38518278/adjunctive-cilostazol-in-patients-with-high-residual-platelet-reactivity-after-drug-eluting-stent-implantation-a-randomized-open-label-single-center-prospective-adjust-hpr-study-erratum
#18
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
March 2024: American Journal of Therapeutics
https://read.qxmd.com/read/38518277/pharmacological-management-of-cholera-a-century-of-expert-opinions-in-cecil-textbook-of-medicine-erratum
#19
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
March 2024: American Journal of Therapeutics
https://read.qxmd.com/read/38518276/efficacy-and-safety-of-insulin-icodec-versus-glargine-u100-a-meta-analysis-of-randomized-controlled-trials-erratum
#20
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
March 2024: American Journal of Therapeutics
journal
journal
32115
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.